Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Outcome of anti-PL12 positive patients with antisynthetase syndrome.

Marie I, Josse S, Decaux O, Dominique S, Landron C, Roblot P, Jouneau S, Vittecoq O, Jouen F.

Presse Med. 2013 Jun;42(6 Pt 1):e153-8. doi: 10.1016/j.lpm.2012.12.003. Epub 2013 Feb 18.

PMID:
23428662
[PubMed - indexed for MEDLINE]
2.

Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.

Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F.

Autoimmun Rev. 2012 Aug;11(10):739-45. doi: 10.1016/j.autrev.2012.01.006. Epub 2012 Feb 3. Review.

PMID:
22326685
[PubMed - indexed for MEDLINE]
3.

Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.

Marie I, Josse S, Decaux O, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Hachulla E, Vittecoq O, Menard JF, Jouen F, Dominique S.

Eur J Intern Med. 2013 Jul;24(5):474-9. doi: 10.1016/j.ejim.2013.01.002. Epub 2013 Feb 1.

PMID:
23375620
[PubMed - indexed for MEDLINE]
4.

Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.

Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, Levesque H, Jouen F.

Semin Arthritis Rheum. 2012 Jun;41(6):890-9. doi: 10.1016/j.semarthrit.2011.09.008. Epub 2011 Nov 9.

PMID:
22078416
[PubMed - indexed for MEDLINE]
5.

Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.

Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O.

Autoimmun Rev. 2012 Dec;12(2):210-7. doi: 10.1016/j.autrev.2012.06.006. Epub 2012 Jul 5.

PMID:
22771754
[PubMed - indexed for MEDLINE]
6.

Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome.

Marie I, Josse S, Hatron PY, Dominique S, Hachulla E, Janvresse A, Cherin P, Mouthon L, Vittecoq O, Menard JF, Jouen F.

Arthritis Care Res (Hoboken). 2013 May;65(5):800-8. doi: 10.1002/acr.21895.

PMID:
23203765
[PubMed - indexed for MEDLINE]
7.

Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases.

Hervier B, Wallaert B, Hachulla E, Adoue D, Lauque D, Audrain M, Camara B, Fournie B, Couret B, Hatron PY, Dubucquoi S, Hamidou M.

Rheumatology (Oxford). 2010 May;49(5):972-6. doi: 10.1093/rheumatology/kep455. Epub 2010 Feb 15.

PMID:
20156976
[PubMed - indexed for MEDLINE]
Free Article
8.

Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.

Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F.

Br J Dermatol. 2010 Feb 1;162(2):337-44. doi: 10.1111/j.1365-2133.2009.09484.x. Epub 2009 Aug 29.

PMID:
19845665
[PubMed - indexed for MEDLINE]
9.

Myositis-related interstitial lung disease and antisynthetase syndrome.

Solomon J, Swigris JJ, Brown KK.

J Bras Pneumol. 2011 Jan-Feb;37(1):100-9. Review. English, Portuguese.

PMID:
21390438
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.

Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, Costedoat-Chalumeau N, Allenbach Y, Hervier B, Dubourg O, Maisonobe T, Charuel JL, Behin A, Herson S, Amoura Z, Grenier P, Benveniste O.

J Rheumatol. 2012 Sep;39(9):1835-9. doi: 10.3899/jrheum.111604. Epub 2012 Aug 1.

PMID:
22859355
[PubMed - indexed for MEDLINE]
11.

[Antisynthetase syndrome: a retrospective study of 14 patients].

Dieval C, Ribeiro E, Mercié P, Blanco P, Duffau P, Longy-Boursier M.

Rev Med Interne. 2012 Feb;33(2):76-9. doi: 10.1016/j.revmed.2011.11.017. Epub 2011 Dec 26. French.

PMID:
22204922
[PubMed - indexed for MEDLINE]
12.

Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.

Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.

Arthritis Rheum. 2005 Aug;52(8):2439-46.

PMID:
16052580
[PubMed - indexed for MEDLINE]
Free Article
13.

Clinical heterogeneity and outcomes of antisynthetase syndrome.

Hervier B, Benveniste O.

Curr Rheumatol Rep. 2013 Aug;15(8):349. doi: 10.1007/s11926-013-0349-8. Review.

PMID:
23794106
[PubMed - indexed for MEDLINE]
14.

Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?

Lega JC, Cottin V, Fabien N, Thivolet-Béjui F, Cordier JF.

J Rheumatol. 2010 May;37(5):1000-9. doi: 10.3899/jrheum.090652. Epub 2010 Mar 15.

PMID:
20231208
[PubMed - indexed for MEDLINE]
15.

Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.

Labirua-Iturburu A, Selva-O'Callaghan A, Martínez-Gómez X, Trallero-Araguás E, Labrador-Horrillo M, Vilardell-Tarrés M.

Clin Exp Rheumatol. 2013 May-Jun;31(3):436-9. Epub 2013 Mar 7.

PMID:
23465087
[PubMed - indexed for MEDLINE]
16.

[Acute interstitial lung disease revealing antisynthetase syndrome].

Bizien N, Renault A, Boles JM, Delluc A.

Rev Pneumol Clin. 2011 Dec;67(6):367-70. doi: 10.1016/j.pneumo.2011.01.003. Epub 2011 Apr 29. French.

PMID:
22137282
[PubMed - indexed for MEDLINE]
17.

Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies.

Mehta P, Patel L, Roncaroli F, Pickering MC, Brand A.

Rheumatol Int. 2012 Mar;32(3):825-7. doi: 10.1007/s00296-011-1811-4. Epub 2011 Feb 17. No abstract available.

PMID:
21328057
[PubMed - indexed for MEDLINE]
18.

Clinical implications of autoantibody screening in patients with autoimmune myositis.

Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A.

Autoimmunity. 2006 May;39(3):217-21.

PMID:
16769655
[PubMed - indexed for MEDLINE]
19.

Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.

Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.

Intern Med J. 2011 Sep;41(9):674-9. doi: 10.1111/j.1445-5994.2010.02164.x. Epub 2010 Jan 4.

PMID:
20059602
[PubMed - indexed for MEDLINE]
20.

The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.

Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, Cordier JF, Cottin V.

Autoimmun Rev. 2014 Sep;13(9):883-91. doi: 10.1016/j.autrev.2014.03.004. Epub 2014 Apr 3.

PMID:
24704867
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk